M.E. Witt

Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience

Bruce Brockstein, Daniel J. Haraf, Alfred Rademaker et al. · Annals of Oncology · 2004 · 368 citations · Full text

Advanced Head, Neck Cancer, Health Sciences +8

Congenital rubella syndrome as a model for Type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies

Fredda Ginsberg‐Fellner, M.E. Witt, Soroku Yagihashi et al. · Diabetologia · 1984 · 151 citations · Full text

Type 1, Congenital Rubella Syndrome, Diabetes +3

Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer

Julia Oh, Everett E. Vokes, M.S. Kies et al. · Annals of Oncology · 2003 · 92 citations · Full text

Health Sciences, Radiation Therapy, Medicine +8

Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels

Joseph K. Salama, K. M. Stenson, Emily O. Kistner et al. · Annals of Oncology · 2008 · 65 citations · Full text

Advanced Head, Neuro-oncology, Radiotherapy Dose Levels +10

A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers

Joseph K. Salama, Daniel J. Haraf, K. M. Stenson et al. · Annals of Oncology · 2011 · 62 citations · Full text

Radiation Therapy, Medicine, T4n0-1 Head +8